We use cookies to give you the best experience possible with our website and to improve our communication with you. We consider your selection and will only use the data you have approved us to gather.

These cookies help making a website usable by enabling basic functions like page navigation and access to secure areas of the website. The website cannot function properly without these cookies.

These cookies help website owners to understand how visitors interact with websites by collecting and reporting information anonymously. With this information we can constantly improve the experience we offer on our website.

These cookies are used to track visitors across websites. The intention is to display ads that are relevant and engaging for the individual user and thereby more valuable for publishers and third party advertisers.

Geistlich Fibro-Gide®

 

Handling of Geistlich Fibro-Gide® is very easy compared to connective tissue grafts:

  • Unlimited availability and consistent quality.1
  • Measure the defect and trim the matrix to the desired size and thickness.1
  • Once moist, the matrix can be further trimmed to the desired size and thickness.1
  • Geistlich Fibro-Gide® can easily be sutured.1
  • No need for pre-treatment: Excellent hydrophilic characteristics lead to rapid hydration by patient’s own blood and/or sterile saline solution with a volume increase of approx. 3-12 %.1
  • The soaked matrix adapts to contours and adheres well to the defect.1
  • Squeezing and re-hydration: Once squeezed, the matrix goes back to its initial state after remoistening (considering the additional swelling of approx. 25 %).1
  • Geistlich Fibro-Gide® does not require a second surgical site.2-4
  • Geistlich Fibro-Gide® should be used as a submerged graft to increase soft-tissue thickness around implants and natural teeth.1

Product availability may vary from country to country.

 

References

  1. Data on file. Geistlich Pharma AG, Wolhusen, Switzerland.
  2. Thoma DS. et al. J Clin Periodontol. 2016 Oct; 43(10): 874–85.
  3. Del Pizzo M. et al. J Clin Periodontol. 2002 Sep; 29(9): 848–54.
  4. Soileau KM. & Brannon RB. J Periodontol. 2006 Jul; 77(7): 1267–73.
Verena Vermeulen
Group Lead Clinical Marketing